Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | 783 ngày trước
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | 983 ngày trước
Australia Rate Decision On Tap For Tuesday

Australia Rate Decision On Tap For Tuesday

The Reserve Bank of Australia will wrap up its monetary policy meeting and then announce its decision on interest rates, highlighting a light day for Asia-Pacific economic activity. The RBA is widely expected to keep its benchmark lending rate unchanged at 3.60 percent.
RTTNews | 1h 41phút trước
Swiss Market Pares Early Gains, Settles Flat

Swiss Market Pares Early Gains, Settles Flat

Save for a brief while during the closing minutes, Switzerland's SMI index stayed positive on Monday, but still ended the session with just a slender gain as several stocks pared early gains due to a lack of support at higher levels.
RTTNews | 5h 58phút trước
European Stocks Close Higher As Investors Asses Economic Data, Recent Earnings

European Stocks Close Higher As Investors Asses Economic Data, Recent Earnings

European markets closed mostly higher on Monday, led by gains in the banking and automobile sectors. Investors assessed U.S.-China trade discussions, recent earnings updates, and digested the latest batch of regional economic data, in addition to awaiting the Bank of England's monetary policy announcement due this week.
RTTNews | 6h 29phút trước
U.S. Manufacturing Index Unexpectedly Edges Lower In October

U.S. Manufacturing Index Unexpectedly Edges Lower In October

Manufacturing activity in the U.S. unexpectedly contracted at a slightly faster rate in the month of October, according to a report released by the Institute for Supply Management on Monday. The ISM said its manufacturing PMI slipped to 48.7 in October after edging up to 49.1 in September, with a reading below 50 indicating contraction. Economists had expected the index to inch up to 49.5.
RTTNews | 8h 44phút trước